The Food and Drug Administration authorized eye drops that may possibly replace reading glasses for millions of people in October, and they entered the market this week.
“It’s definitely a life changer,” trial participant Toni Wright told CBS. “I would not need my readers as much, especially on the computer, where I would always need to have them on.”
The drops, known as pilocarpine, and sold by pharma outlet Allergan under the name “Vuity,” might help the 128 million people in the United States who are nearsighted. One drop in each eye, according to the business, may enhance closeup eyesight for six to ten hours, according to CBS News.
The drops function by utilizing the eye’s natural capacity to shrink its pupil.
“Reducing the pupil size expands the depth of field or the depth of focus, and that allows you to focus at different ranges naturally,” George Waring, lead investigator of a clinical trial, told CBS.
At $80 for a 30-day supply, the drops aren’t cheap, but they’re also not excessively pricey, considering the benefit..
However, it is not a cure-all, and headaches and burning eyes are two of the most common adverse effects reported. The manufacturer also advises against using the drops at night while driving or when operating machinery.
Middle-aged adults are the ones who benefit the most from the drops. According to CBS, those over the age of 65 will be less affected by them.
Millions of people find wearing reading glasses inconvenient, therefore getting rid of them is surely appealing.
Along with revolutionary technologies like Lasik, humans are continually moving towards a future where problems with eyesight are a thing of the past. Nice.
Typos, corrections and/or news tips? Email us at [email protected]